Recombinant multi-species G6PD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine G6PD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CNSHA1,G28A,G6PD,G6PD1,G6pd,G6pdx,Glucose-6-phosphate 1-dehydrogenase,Gpdx

Target products collectionGo to G6PD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T63484-Ag-1/ GM-Tg-hg-T63484-Ag-2 Human G6PD protein Human
GM-Tg-rg-T63484-Ag-1/ GM-Tg-rg-T63484-Ag-2 Rat G6PD protein Rat
GM-Tg-mg-T63484-Ag-1/ GM-Tg-mg-T63484-Ag-2 Mouse G6PD protein Mouse
GM-Tg-cynog-T63484-Ag-1/ GM-Tg-cynog-T63484-Ag-2 Cynomolgus/Rhesus macaque G6PD protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T63484-Ag-1/ GM-Tg-felg-T63484-Ag-2 Feline G6PD protein Feline
GM-Tg-cang-T63484-Ag-1/ GM-Tg-cang-T63484-Ag-2 Canine G6PD protein Canine
GM-Tg-bovg-T63484-Ag-1/ GM-Tg-bovg-T63484-Ag-2 Bovine G6PD protein Bovine
GM-Tg-equg-T63484-Ag-1/ GM-Tg-equg-T63484-Ag-2 Equine G6PD protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T63484-Ag-1/ GM-Tg-hg-T63484-Ag-2; GM-Tg-rg-T63484-Ag-1/ GM-Tg-rg-T63484-Ag-2;
GM-Tg-mg-T63484-Ag-1/ GM-Tg-mg-T63484-Ag-2; GM-Tg-cynog-T63484-Ag-1/ GM-Tg-cynog-T63484-Ag-2;
GM-Tg-felg-T63484-Ag-1/ GM-Tg-felg-T63484-Ag-2; GM-Tg-cang-T63484-Ag-1/ GM-Tg-cang-T63484-Ag-2;
GM-Tg-bovg-T63484-Ag-1/ GM-Tg-bovg-T63484-Ag-2; GM-Tg-equg-T63484-Ag-1/ GM-Tg-equg-T63484-Ag-2
Products Name G6PD protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name G6PD
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine G6PD protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.